Digital Health Technology in Asthma: A Comprehensive Scoping Review
Giselle Mosnaim(NorthShore University HealthSystem), Rajan Merchant(Dignity Health), Randall W. Brown, Leonard B. Bacharier(Washington University in St. Louis), Guilherme Safioti(Teva Pharmaceuticals (Netherlands)), Don A. Bukstein(Institute for Asthma and Allergy), Michael DePietro(Teva Pharmaceuticals (United States)), Stanley J. Szefler(Children's Hospital Colorado), David M. Lang(Cleveland Clinic), Jay M. Portnoy(Children's Mercy Hospital)
The Journal of Allergy and Clinical Immunology In Practice
February 27, 2021
Cited by 119
Related Papers
Long-Term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma
|New England Journal of Medicine|2006|1.1k
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
|Journal of Allergy and Clinical Immunology|2007|933
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
|New England Journal of Medicine|2011|870
Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis
|Journal of Allergy and Clinical Immunology|2020|690
Characterization of within-subject responses to fluticasone and montelukast in childhood asthma
|Journal of Allergy and Clinical Immunology|2005|591